Clinical Trial Update: Safety and Efficacy of INCB013739 Plus Metformin Compared to Metformin Alone on Glycemic Control in Type 2 Diabetics [Phase 2]

View source ↗

Summary

Phase 2 trial updates safety and efficacy of INCB013739 plus metformin versus metformin alone for glycemic control in type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• INCB013739
• metformin (metformin)

Snippet

Sponsor: Incyte Corporation | Conditions: Type 2 Diabetes | Phase 2 | Status: COMPLETED